Delayed contrast–enhanced MRI: use in myocardial viability assessment and other cardiac pathology
- 1 March 2005
- journal article
- research article
- Published by Springer Nature in European Radiology Supplements
- Vol. 15 (2) , B52-B58
- https://doi.org/10.1007/s10406-005-0093-x
Abstract
As in other organs, tissue characterization is important for many cardiac diseases. For example, in ischemic heart disease, differentiation between reversibly and irreversibly damaged myocardium in patients with a prior myocardial infarction is crucial in determining disease severity, functional recovery and patient outcome. With the recent advent of the single inversion-recovery contrast-enhanced magnetic resonance imaging (MRI) sequence (delayed contrast-enhanced MRI), contrast between normal and abnormal tissues could be significantly enhanced compared with the conventional cardiac MRI sequences, enabling even subtle abnormalities to be visualized. Together with other advances in cardiac MRI (e.g. functional imaging, coronary artery imaging), MRI has become one of the preferred non-invasive modalities to study cardiac diseases. In this paper an overview of the versatility of delayed contrast-enhanced MRI for investigating cardiac diseases is given.Keywords
This publication has 0 references indexed in Scilit: